Nexien BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Mar '26 Mar 6, 2026	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019 - 2017
Market Capitalization	0	1	2	4	5	3	Upgrade
Market Cap Growth	-99.61%	-47.97%	-39.49%	-24.47%	90.11%	-45.30%	Upgrade
Enterprise Value	0	1	3	4	5	3	Upgrade
Last Close Price	0.00	0.02	0.04	0.06	0.09	0.05	Upgrade
PB Ratio	-0.02	-3.30	-9.08	-32.16	-363.58	-413.89	Upgrade
Debt / Equity Ratio	-0.83	-0.86	-1.08	-1.88	-2.39	-1.88	Upgrade
Net Debt / Equity Ratio	-0.81	-0.85	-0.94	-0.89	-1.08	-0.19	Upgrade
Quick Ratio	0.02	0.01	0.12	0.48	0.46	0.37	Upgrade
Current Ratio	0.02	0.01	0.15	0.51	0.65	0.78	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-2058.62%	Upgrade
Return on Assets (ROA)	-655.83%	-411.28%	-210.72%	-469.81%	-4769.09%	-988.36%	Upgrade
Return on Capital Employed (ROCE)	26.30%	43.10%	112.10%	479.60%	13384.90%	41423.20%	Upgrade
Earnings Yield	-2657.65%	-20.08%	-15.81%	-16.56%	-37.14%	-101.41%	Upgrade
Buyback Yield / Dilution	-8.06%	-6.19%	-7.73%	-4.44%	-2.76%	-5.64%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.